FDA.reportPublic FDA data

imipenem / cilastatin 250 MG Injection

RxCUI
1726204
RxNorm name
imipenem / cilastatin 250 MG Injection
Display name
imipenem / cilastatin 250 MG Injection
Full name
imipenem / cilastatin 250 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PRIMAXIN IVIMIPENEM AND CILASTATIN SODIUMMerck Sharp & Dohme LLCf41d8abd-7792-4918-1b93-bd83ea01955e2024-07-05Warnings, Adverse reactionsExact identifier
rxcui: 1726204
Imipenem and CilastatinIMIPENEM AND CILASTATIN SODIUMFresenius Kabi USA, LLCce771566-c4f2-447e-944a-6b908925c90b2022-10-11Warnings, Adverse reactionsExact identifier
rxcui: 1726204
Imipenem and CilastatinIMIPENEM AND CILASTATIN SODIUMFresenius Kabi USA, LLC0a1dd9b9-ada1-4bff-9dcb-18961254e9e82022-10-10Warnings, Adverse reactionsExact identifier
rxcui: 1726204
Imipenem and CilastatinIMIPENEM AND CILASTATIN SODIUMFresenius Kabi USA, LLC6ab0ca9e-9a79-4cab-9f09-470eda06952e2022-10-06Warnings, Adverse reactionsExact identifier
rxcui: 1726204

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 4 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f41d8abd-7792-4918-1b93-bd83ea01955eimipenem / cilastatin 250 MG Injection [PSN] · cilastatin 250 MG / imipenem 250 MG Injection [SCD] · cilastatin (as cilastatin sodium) 250 MG / imipenem 250 MG Injection [SY] · imipenem 250 MG / cilastatin 250 MG Injection [SY]434These highlights do not include all the information needed to use PRIMAXIN safely and effectively. See full prescribing information for PRIMAXIN. PRIMAXIN® (imipenem and cilastatin) for Injection, for intravenous use Initial U.S. Approval: 198520240705
6ab0ca9e-9a79-4cab-9f09-470eda06952eimipenem / cilastatin 250 MG Injection [PSN] · cilastatin 250 MG / imipenem 250 MG Injection [SCD] · cilastatin (as cilastatin sodium) 250 MG / imipenem 250 MG Injection [SY] · imipenem 250 MG / cilastatin 250 MG Injection [SY]412These highlights do not include all the information needed to use Imipenem and Cilastatin for Injection, USP (I.V.) safely and effectively. See full prescribing information for Imipenem and Cilastatin for Injection, USP (I.V.). IMIPENEM AND CILASTATIN FOR INJECTION, USP, for intravenous use Initial U.S. Approval: 198520221006
0a1dd9b9-ada1-4bff-9dcb-18961254e9e8imipenem / cilastatin 250 MG Injection [PSN] · cilastatin 250 MG / imipenem 250 MG Injection [SCD] · cilastatin (as cilastatin sodium) 250 MG / imipenem 250 MG Injection [SY] · imipenem 250 MG / cilastatin 250 MG Injection [SY]47These highlights do not include all the information needed to use Imipenem and Cilastatin for Injection, USP (I.V.) safely and effectively. See full prescribing information for Imipenem and Cilastatin for Injection, USP (I.V.). IMIPENEM AND CILASTATIN FOR INJECTION, USP, for intravenous use Initial U.S. Approval: 198520221010
ce771566-c4f2-447e-944a-6b908925c90bimipenem / cilastatin 250 MG Injection [PSN] · cilastatin 250 MG / imipenem 250 MG Injection [SCD] · cilastatin (as cilastatin sodium) 250 MG / imipenem 250 MG Injection [SY] · imipenem 250 MG / cilastatin 250 MG Injection [SY]45These highlights do not include all the information needed to use Imipenem and Cilastatin for Injection, USP (I.V.) safely and effectively. See full prescribing information for Imipenem and Cilastatin for Injection, USP (I.V.). IMIPENEM AND CILASTATIN FOR INJECTION, USP, for intravenous use Initial U.S. Approval: 198520221011